Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 353

1.

Regulation of glucocorticoid receptor in nasal polyps by systemic and intranasal glucocorticoids.

Pujols L, Alobid I, Benítez P, Martínez-Antón A, Roca-Ferrer J, Fokkens WJ, Mullol J, Picado C.

Allergy. 2008 Oct;63(10):1377-86. doi: 10.1111/j.1398-9995.2008.01745.x. Epub 2008 Jul 26.

2.

Expression of the glucocorticoid receptor alpha and beta isoforms in human nasal mucosa and polyp epithelial cells.

Pujols L, Mullol J, Benítez P, Torrego A, Xaubet A, de Haro J, Picado C.

Respir Med. 2003 Jan;97(1):90-6.

PMID:
12556018
3.

Corticosteroid therapy increases membrane-tethered while decreases secreted mucin expression in nasal polyps.

Martínez-Antón A, de Bolós C, Alobid I, Benítez P, Roca-Ferrer J, Picado C, Mullol J.

Allergy. 2008 Oct;63(10):1368-76. doi: 10.1111/j.1398-9995.2008.01678.x. Epub 2008 Jun 5.

4.

GRbeta expression in nasal polyp inflammatory cells and its relationship to the anti-inflammatory effects of intranasal fluticasone.

Hamilos DL, Leung DY, Muro S, Kahn AM, Hamilos SS, Thawley SE, Hamid QA.

J Allergy Clin Immunol. 2001 Jul;108(1):59-68.

PMID:
11447383
5.

Glucocorticoid receptor expression and glucocorticoid therapeutic effect in nasal polyps.

Li P, Li Y, Li YQ, Yang QT, Zhang GH.

Clin Invest Med. 2010 Jun 1;33(3):E181-8.

PMID:
20519097
6.

A short course of oral prednisone followed by intranasal budesonide is an effective treatment of severe nasal polyps.

Benítez P, Alobid I, de Haro J, Berenguer J, Bernal-Sprekelsen M, Pujols L, Picado C, Mullol J.

Laryngoscope. 2006 May;116(5):770-5.

PMID:
16652085
7.

Glucocorticoid receptor in human respiratory epithelial cells.

Pujolsa L, Mullol J, Picado C.

Neuroimmunomodulation. 2009;16(5):290-9. doi: 10.1159/000216187. Epub 2009 Jun 29. Review.

PMID:
19571590
8.

Tissue mRNA expression of the glucocorticoid receptor and its splice variants in fatal critical illness.

Peeters RP, Hagendorf A, Vanhorebeek I, Visser TJ, Klootwijk W, Mesotten D, Wouters PJ, Koper JW, de Jong FH, Feelders RA, Lamberts SW, Van den Berghe G.

Clin Endocrinol (Oxf). 2009 Jul;71(1):145-53. doi: 10.1111/j.1365-2265.2008.03443.x. Epub 2008 Oct 13.

PMID:
19178514
10.

Severe nasal polyposis and its impact on quality of life. The effect of a short course of oral steroids followed by long-term intranasal steroid treatment.

Alobid I, Benitez P, Pujols L, Maldonado M, Bernal-Sprekelsen M, Morello A, Picado C, Mullol J.

Rhinology. 2006 Mar;44(1):8-13.

PMID:
16550943
11.

Evaluating budesonide efficacy in nasal polyposis and predicting the resistance to treatment.

Valera FC, Queiroz R, Scrideli C, Tone LG, Anselmo-Lima WT.

Clin Exp Allergy. 2009 Jan;39(1):81-8. doi: 10.1111/j.1365-2222.2008.03144.x. Epub 2008 Nov 26.

PMID:
19068102
12.

Glucocorticoid receptors in human airways.

Pujols L, Mullol J, Torrego A, Picado C.

Allergy. 2004 Oct;59(10):1042-52. Review.

13.

Expression of glucocorticoid receptors alpha and beta in steroid sensitive and steroid insensitive interstitial lung diseases.

Pujols L, Xaubet A, Ramírez J, Mullol J, Roca-Ferrer J, Torrego A, Cidlowski JA, Picado C.

Thorax. 2004 Aug;59(8):687-93.

14.

Differential mRNA expression of glucocorticoid receptor alpha and beta is associated with glucocorticoid sensitivity of acute lymphoblastic leukemia in children.

Koga Y, Matsuzaki A, Suminoe A, Hattori H, Kanemitsu S, Hara T.

Pediatr Blood Cancer. 2005 Aug;45(2):121-7.

PMID:
15704223
15.

Corticosteroid treatment regulates mucosal remodeling in chronic rhinosinusitis with nasal polyps.

de Borja Callejas F, Martínez-Antón A, Picado C, Alobid I, Pujols L, Valero A, Roca-Ferrer J, Mullol J.

Laryngoscope. 2015 May;125(5):E158-67. doi: 10.1002/lary.25147. Epub 2015 Jan 13.

PMID:
25641502
16.

Alpha and beta glucocorticoid receptors: relevance in airway diseases.

Pujols L, Mullol J, Picado C.

Curr Allergy Asthma Rep. 2007 May;7(2):93-9. Review.

PMID:
17437678
17.

Oral and intranasal steroid treatments improve nasal patency and paradoxically increase nasal nitric oxide in patients with severe nasal polyposis.

Alobid I, Benitez P, Valero A, Munoz R, Langdon C, Mullol J.

Rhinology. 2012 Jun;50(2):171-7. doi: 10.4193/Rhino10.140.

PMID:
22616078
18.

Glucocorticoid therapy increases COX-2 gene expression in nasal polyps in vivo.

Pujols L, Benitez P, Alobid I, Martinez-Antón A, Roca-Ferrer J, Mullol J, Picado C.

Eur Respir J. 2009 Mar;33(3):502-8. doi: 10.1183/09031936.00017408. Epub 2008 Nov 14.

19.

Low expression of glucocorticoid receptor alpha isoform in adult immune thrombocytopenia correlates with glucocorticoid resistance.

Ma L, Fang M, Liang Y, Xiang Y, Jia Z, Sun X, Wang Y, Qin J.

Ann Hematol. 2013 Jul;92(7):953-60. doi: 10.1007/s00277-013-1705-5. Epub 2013 Feb 24.

PMID:
23435844
20.

Regulation of glucocorticoid receptor mRNA in nasal mucosa by local administration of fluticasone and budesonide.

Knutsson PU, Brönnegård M, Marcus C, Stierna P.

J Allergy Clin Immunol. 1996 Feb;97(2):655-61.

PMID:
8621851

Supplemental Content

Support Center